The tissue-resident Fc Receptor-Like 4 (FcRL4)+ B cell subset was recently reported to be a key driver in SS patients with mucosa-associated lymphoid tissue (MALT)-lymphomas, and FcRL4+ B cells are expanded in SS patients’ inflammatory tissues (39, 40). This evidence concerns the gene FCRL4 and synovial sarcoma.